Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing the acquisition of an additional ...

Global chemical company Evonik has announced that VECOLLAN®, its recombinant, non-animal-derived collagen-like protein ...

Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On September 15, 2025, Amphastar Pharmaceuticals entered into a contract research ...

Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click here to find out why ...

What if you'd invested in Halozyme Therapeutics (HALO) ten years ago? It may not have been easy to hold on to HALO for all that time, but if you did, how much would your investment be worth today?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will donate up to 500 doses of Inmazeb ® (atoltivimab, maftivimab, and odesivimab-ebgn), an Ebola treatment for the infection ...

Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...

The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven ...

Intracellular Signaling Domain: Activates the T cell upon antigen engagement. It usually contains the CD3ζ chain or CD3ε derived from the T-cell receptor, plus costimulatory domains such as CD28 or ...

The global Medical Device Technology Market is on an accelerated growth path, estimated at USD 575.6 billion in 2025 and ...

Thermo Fisher Scientific has launched Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed to enhance ...